Analyst firms · Morgan Stanley · ALAB
Morgan Stanley ALAB price target and rating history
Astera Labs Inc. (ALAB) · Technology
Morgan Stanley rates Astera Labs Inc. (ALAB) Overweight with a $99 price target, as of its latest action on May 12, 2025. It has published 4 rating actions on ALAB since April 2024, including 2 upgrades and 1 downgrade. Across 7 firms with a ALAB price target in the last 12 months, the median target is $225.
- Current rating
- Overweight
- Price target
- $99
- Median target, all firms
- $225
- Actions on ALAB
- 4
Morgan Stanley price target on ALAB
Every Morgan Stanley rating on ALAB
- May 12, 2025
- Jan 21, 2025
- Sep 4, 2024
- Apr 15, 2024
How other firms rate ALAB
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $375 | Nov 5, 2026 |
| Northland Capital Markets | Outperform | $315 | Nov 4, 2026 |
| Rothschild & Co Redburn | Neutral | $153 | May 1, 2026 |
| UBS | Neutral | $180 | Apr 21, 2026 |
| Citigroup | Buy | $200 | Apr 3, 2026 |
| Loop Capital | Buy | $250 | Mar 5, 2026 |
| RBC Capital Markets | Outperform | Jan 15, 2026 | |
| Raymond James | Mkt Perform | Nov 21, 2025 | |
| BNP Paribas Exane | Outperform | $225 | Nov 20, 2025 |
Questions about Morgan Stanley and ALAB
- What is Morgan Stanley's price target for ALAB?
- Morgan Stanley's latest stated price target for Astera Labs Inc. (ALAB) is $99, from its action on May 12, 2025.
- What is Morgan Stanley's rating on ALAB?
- Morgan Stanley rates ALAB Overweight, a bullish rating, as of May 12, 2025.
- When did Morgan Stanley last change its view on ALAB?
- On May 12, 2025, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $99.
- How does Morgan Stanley's ALAB target compare with other analysts?
- Across 7 firms with a ALAB price target in the last 12 months, the median target is $225.
More ALAB rating histories
All Morgan Stanley ratingsALAB news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.